EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pharmacokinetics of intranasal levetiracetam in healthy dogs: a feasible route of administration

Ewa Krolak iD, Kamoltip Thungrat iD, Amanda Gross iD, Katherine Gerken iD, Kendon Kuo iD, Tom Jukier iD

American Journal of Veterinary Research · 2025

DOI: 10.2460/ajvr.25.10.0366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2025. Verfasst von Ewa Krolak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, AL. Hauptthemen laut MEDLINE: Levetiracetam, Anticonvulsants. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To describe the pharmacokinetics of the IV formulation of levetiracetam administered intranasally and calculate the absolute bioavailability. Our hypothesis was that levetiracetam would show near complete absorption following a single intranasal dose.

Methods

8 healthy dogs (4 female, 4 male) from a canine colony were used in a crossover study comparing the pharmacokinetics of intranasal and IV levetiracetam. The study occurred from August through September 2024. A 100-mg dose of levetiracetam was administered via the intranasal and IV routes on separate occasions. Blood was collected from jugular catheters over a 24-hour period following dose administration. Plasma levetiracetam concentrations were analyzed using high-pressure liquid chromatography. Noncompartmental analysis was performed to describe the pharmacokinetics.

Results

Median (minimum to maximum), maximal concentration, time to maximal concentration, and elimination half-life for the intranasal route were 7.85 µg/mL (range, 3.37 to 14.16), 0.98 hours (range, 0.22 to 1.00), and 2.83 hours (range, 2.44 to 3.76), respectively. Median (minimum to maximum) bioavailability was 61% (range, 34% to 85%). The maximal concentration achieved fell within the human reference interval for levetiracetam in 5 of 8 dogs.

Conclusions

Levetiracetam was absorbed to a moderate degree following the intranasal route of administration and appeared to be well tolerated. Clinical Relevance Levetiracetam is absorbed via the nasal administration route and could be considered a feasible route of administration for at-home rescue protocols. Although concentrations within the human reference interval were achieved in a majority of dogs, a clinical trial is necessary to determine if this method of administration would be effective in a clinical setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevetiracetamAnticonvulsantsAnimalsDogsAdministration, IntranasalMaleFemaleCross-Over StudiesBiological AvailabilityHalf-LifeArea Under Curve

Stichwörter der Autor:innen

canine seizuresintranasal administrationlevetiracetampharmacokineticsrescue therapy

Substanzen

LevetiracetamAnticonvulsants

Autor:innen und Institutionen

  • Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, AL.
  • Department of Anatomy, Physiology, and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL.
  • Scott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, Auburn, AL.

ORCID-Profile: Ewa Krolak, Kamoltip Thungrat, Amanda Gross, Katherine Gerken, Kendon Kuo, Tom Jukier

Zitieren

APA

Krolak, E., Thungrat, K., Gross, A., Gerken, K., Kuo, K., & Jukier, T. (2025). Pharmacokinetics of intranasal levetiracetam in healthy dogs: a feasible route of administration. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.25.10.0366

Vancouver

Krolak E, Thungrat K, Gross A, Gerken K, Kuo K, Jukier T. Pharmacokinetics of intranasal levetiracetam in healthy dogs: a feasible route of administration. American Journal of Veterinary Research. 2025. doi:10.2460/ajvr.25.10.0366

BibTeX
@article{Krolak2025,
  author = {Krolak, Ewa and Thungrat, Kamoltip and Gross, Amanda and Gerken, Katherine and Kuo, Kendon and Jukier, Tom},
  title = {Pharmacokinetics of intranasal levetiracetam in healthy dogs: a feasible route of administration},
  journal = {American Journal of Veterinary Research},
  year = {2025},
  doi = {10.2460/ajvr.25.10.0366}
}
Kostenlos starten →